ArticleCell reports methods2026
A generative framework for predicting cellular morphological and transcriptomic perturbation responses.
Article in Cell reports methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Predicting coordinated cellular responses to perturbations is crucial for phenotypic drug discovery and building virtual cell models. Current methods typically predict isolated modalities or require empirical post-perturbation data, precluding true de novo virtual screening. To address this, we introduce MultiVCDiff, a unified multimodal generative diffusion framework that simultaneously predicts high-fidelity cellular morphology images and transcriptomic profiles directly from chemical or genetic perturbations. This framework was trained on a comprehensive trimodal corpus encompassing 1,118 chemical and 130 genetic perturbations across four datasets. Evaluated under strict zero-shot settings on unseen drugs, MultiVCDiff outperforms state-of-the-art single-modality baselines. It successfully overcomes morphological mode collapse, generates highly accurate gene expression signatures, and captures complex biological relationships to reliably retrieve drug mechanisms of action. By eliminating the dependency on prior post-perturbation readouts, MultiVCDiff enables scalable in silico hypothesis generation, significantly accelerating drug discovery and advancing holistic virtual cell modeling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.